Carlyle Group Inc. (CG): debt financing — Carlyle Group enters Third Amended Credit Agreement, extends $1B facility to 2030

Carlyle Group Inc.

Third Amended and Restated Credit Agreement signed May 29, 2025; $1.0B revolving facility maintained, no amounts drawn.
Maturity extended to May 29, 2030 from April 29, 2027; ability to increase facility by up to $250M.
Interest rates: base rate + up to 0.50% or SOFR + 0.10% + up to 1.50% margin; commitment fee up to 0.15%.
Financial covenants: management fee earning assets ≥ $156.9B, total leverage ratio < 4.0x; tested quarterly.
Annual Meeting results: all eight directors elected; auditor ratified; say-on-pay passed with ~206.5M for, 87M against.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Carlyle Group Inc. amended revolving credit of $1.0 billion with Citibank, N.A. at alternate base rate plus an applicable margin not to exceed 0.50% per annum, or maturing May 29, 2030.

Instrument: revolving credit
Principal: $1.0 billion
Counterparty: Citibank, N.A.
Rate: alternate base rate plus an applicable margin not to exceed 0.50% per annum, or
Maturity: May 29, 2030
Event: amendment

Exact text from the filing

as Administrative Agent. In connection with entering into the Third Amended and Restated Credit Agreement, the Company maintained the size of its revolving credit facility at $1.0 billion. The Company currently has no amounts outstanding under the revolving credit facility. The Company has the ability to increase the size of its revolving credit facility (and/or

View on SEC.gov

26 debt financings filed in the last 30 days. Browse all debt financings →

Carlyle Group Inc. filing history →

Source: SEC EDGAR

accession 0001527166-25-000085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.